BR112017024734A2 - método e dispositivo para realizar uma pluralidade de processos de síntese de preparação de um radiofármaco em série, e, cassete. - Google Patents

método e dispositivo para realizar uma pluralidade de processos de síntese de preparação de um radiofármaco em série, e, cassete.

Info

Publication number
BR112017024734A2
BR112017024734A2 BR112017024734-8A BR112017024734A BR112017024734A2 BR 112017024734 A2 BR112017024734 A2 BR 112017024734A2 BR 112017024734 A BR112017024734 A BR 112017024734A BR 112017024734 A2 BR112017024734 A2 BR 112017024734A2
Authority
BR
Brazil
Prior art keywords
radiopharmaceutical
cassette
synthesis
preparing
anion exchange
Prior art date
Application number
BR112017024734-8A
Other languages
English (en)
Other versions
BR112017024734B1 (pt
Inventor
Luc Antoine Tadino Vincent
André René Villeret Guillaume
Original Assignee
Out And Out Chemistry S.P.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Out And Out Chemistry S.P.R.L. filed Critical Out And Out Chemistry S.P.R.L.
Publication of BR112017024734A2 publication Critical patent/BR112017024734A2/pt
Publication of BR112017024734B1 publication Critical patent/BR112017024734B1/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D3/00—Halides of sodium, potassium or alkali metals in general
    • C01D3/02—Fluorides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/40—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton with quaternised nitrogen atoms bound to carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24—Halogenated derivatives
    • C07C39/40—Halogenated derivatives with at least one hydroxy group on a condensed ring system containing more than two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/16—Halogenated acetic acids
    • C07C53/18—Halogenated acetic acids containing fluorine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/24—Stationary reactors without moving elements inside
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings

Abstract

a invenção se refere a um método para realizar uma pluralidade de processos de síntese de preparação de um radiofármaco em série, método este que compreende realizar uma primeira execução de síntese compreendendo as etapas de: a) prover água contendo 18f; b) captar o 18f da água provida na etapa a) em um material de troca aniônica (18); c) eluir o 18f captado do material de troca aniônica (18) para um vaso de reação (58) do primeiro cassete de síntese de radiofármacos (50?); d) preparar um radiofármaco que incorpora o 18f eluído usando o primeiro cassete de síntese de radiofármacos (50?); em que as etapas a) a d) são repetidas em pelo menos uma execução subsequente usando um outro cassete de síntese de radiofármacos (50?; 50??); e em que o método compreende uma etapa de recondicionamento de dito material de troca aniônica (18) entre duas execuções consecutivas. outros aspectos da invenção se referem a um dispositivo para realizar esse método, e um cassete para uso no dispositivo.
BR112017024734-8A 2015-05-20 2016-05-19 Método e dispositivo para realizar uma pluralidade de processos de síntese de preparação de um radiofármaco em série, e, cassete BR112017024734B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL2014828A NL2014828B1 (en) 2015-05-20 2015-05-20 Method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, a device and cassette for performing this method.
NL2014828 2015-05-20
PCT/EP2016/061319 WO2016184980A1 (en) 2015-05-20 2016-05-19 Method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, a device and cassette for performing this method

Publications (2)

Publication Number Publication Date
BR112017024734A2 true BR112017024734A2 (pt) 2018-07-31
BR112017024734B1 BR112017024734B1 (pt) 2021-10-13

Family

ID=53502792

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017024734-8A BR112017024734B1 (pt) 2015-05-20 2016-05-19 Método e dispositivo para realizar uma pluralidade de processos de síntese de preparação de um radiofármaco em série, e, cassete

Country Status (13)

Country Link
US (3) US10344045B2 (pt)
EP (1) EP3297977B1 (pt)
JP (1) JP6664856B2 (pt)
KR (1) KR102632284B1 (pt)
CN (1) CN107635949B (pt)
BE (1) BE1023528B1 (pt)
BR (1) BR112017024734B1 (pt)
CA (1) CA2986186A1 (pt)
DK (1) DK3297977T3 (pt)
IL (1) IL255721B (pt)
NL (1) NL2014828B1 (pt)
RU (1) RU2721551C2 (pt)
WO (1) WO2016184980A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201805283D0 (en) * 2018-03-29 2018-05-16 Ge Healthcare Ltd Method of synthesizing a radiopharmaceutical
FR3111133A1 (fr) * 2020-06-04 2021-12-10 Université du Mans Procede de traitement chimique automatise d’un substrat solide par une ligne de fluoration
CN113413840A (zh) * 2021-06-04 2021-09-21 四川玖谊源粒子科技有限公司 一种用于制备多核素放射性药物的合成系统
KR20230077672A (ko) 2021-11-22 2023-06-01 가천대학교 산학협력단 방사성 플루오로화 나트륨의 연속 제조 방법

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2191853A (en) 1936-02-24 1940-02-27 Holmes Eric Leighton Use of synthetic resins
BE895821A (fr) 1983-02-04 1983-05-30 Ecolochem Inc Systeme mobile pour la purification de fluides
JPH11295494A (ja) 1998-04-08 1999-10-29 Nippon Meji Physics Kk ［ｆ−１８］−フッ化物イオンの製造方法
US6599484B1 (en) * 2000-05-12 2003-07-29 Cti, Inc. Apparatus for processing radionuclides
US6567492B2 (en) 2001-06-11 2003-05-20 Eastern Isotopes, Inc. Process and apparatus for production of F-18 fluoride
JP2006527367A (ja) * 2003-04-22 2006-11-30 モレキュラー テクノロジーズ インコーポレイテッド Ｆｄｇ等の分子画像化プローブを合成するためのシステム及び方法
JP4113053B2 (ja) 2003-06-13 2008-07-02 株式会社東芝 ウラン廃棄物の湿式処理方法および装置
GB201420094D0 (en) 2014-11-12 2014-12-24 Ge Healthcare Ltd Flouride trapping arrangement
EP1880288A4 (en) * 2005-04-29 2011-03-30 Barclays Capital Inc SYSTEM AND METHOD FOR CONTACTS MANAGEMENT
US7235216B2 (en) 2005-05-01 2007-06-26 Iba Molecular North America, Inc. Apparatus and method for producing radiopharmaceuticals
CN100374453C (zh) * 2005-11-18 2008-03-12 南方医科大学南方医院 2－18f－2－脱氧－d－葡萄糖的合成工艺
US7586102B2 (en) 2006-08-14 2009-09-08 Board Of Regents The University Of Texas System Automated system for formulating radiopharmaceuticals
KR20090096716A (ko) * 2007-01-09 2009-09-14 바이엘 쉐링 파마 악티엔게젤샤프트 아지리딘의 플루오르화에 의한 방사성표지
CN101104627A (zh) 2007-07-20 2008-01-16 张锦明 18f－fdg自动化合成方法及设备
EP2110367A1 (en) * 2008-04-14 2009-10-21 Bayer Schering Pharma Aktiengesellschaft Purification strategy for direct nucleophilic procedures
US20110184159A1 (en) 2008-07-07 2011-07-28 Bayer Schering Pharma Aktiengesellschaft Process for production of radiopharmaceuticals
CN101333138B (zh) 2008-07-23 2011-01-19 北京师范大学 一种能同时制备三种不同18f放射性药物的装置与工艺
CN102292461A (zh) * 2008-12-22 2011-12-21 拜耳先灵医药股份有限公司 使用交换树脂合成放射性核素标记的化合物的方法
US8435454B2 (en) 2009-07-09 2013-05-07 Siemens Medical Solutions Usa, Inc. Modular system for radiosynthesis with multi-run capabilities and reduced risk of radiation exposure
EP2534136B1 (en) * 2010-02-08 2017-09-06 Lantheus Medical Imaging, Inc. Methods for synthesizing imaging agents, and intermediates thereof
CA2795762C (en) 2010-04-08 2017-03-28 Siemens Medical Solutions Usa, Inc. Synthesis of 18f-labeled tracers in hydrous organic solvents
WO2011141410A1 (en) 2010-05-10 2011-11-17 Technische Universität München Method for the direct elution of reactive [18f]fluoride from an anion exchange resin in an organic medium suitable for radiolabelling without any evaporation step by the use of alkalimetal and alkaline earth metal cryptates
KR20140006783A (ko) * 2010-09-09 2014-01-16 피라말 이미징 에스에이 친핵성 ［18ｆ］플루오린화에 적합한 ［18ｆ］플루오라이드의 신속한 제조 방법
EP2652745A1 (en) * 2010-12-17 2013-10-23 GE Healthcare UK Limited Shielding collar
WO2012089594A1 (en) * 2010-12-29 2012-07-05 Ge Healthcare Limited Eluent solution
US20130102772A1 (en) 2011-07-15 2013-04-25 Cardinal Health 414, Llc Systems, methods and devices for producing, manufacturing and control of radiopharmaceuticals-full
CN103946925A (zh) * 2011-09-30 2014-07-23 通用电气健康护理有限公司 分区的反应容器
CN103827975A (zh) 2011-09-30 2014-05-28 通用电气健康护理有限公司 用于放射药剂合成的盒
CN103974762A (zh) * 2011-09-30 2014-08-06 通用电气健康护理有限公司 用于多步放射化学的反应器
RU2587033C2 (ru) * 2012-02-28 2016-06-10 Аут Энд Аут Кемистри Спрл Пневматическое устройство для контроля клапанов
WO2013188459A2 (en) 2012-06-11 2013-12-19 Hns International, Inc. Lancet devices without needle and related methods
WO2014018419A1 (en) 2012-07-21 2014-01-30 K-Technologies, Inc. Processes for the recovery of fluoride and silica products and phosphoric acid from wet-process phosphoric acid facilities and contaminated waste waters
KR102335535B1 (ko) 2013-11-13 2021-12-08 지이 헬쓰케어 리미티드 18f-표지된 화합물의 합성을 위한 이중 실행 카세트

Also Published As

Publication number Publication date
WO2016184980A1 (en) 2016-11-24
IL255721B (en) 2020-01-30
EP3297977A1 (en) 2018-03-28
US11820790B2 (en) 2023-11-21
BE1023528B1 (fr) 2017-04-21
CA2986186A1 (en) 2016-11-24
KR102632284B1 (ko) 2024-02-01
US20240059724A1 (en) 2024-02-22
CN107635949B (zh) 2021-02-02
EP3297977B1 (en) 2019-12-18
JP6664856B2 (ja) 2020-03-13
BR112017024734B1 (pt) 2021-10-13
RU2017143907A3 (pt) 2019-10-28
US20180118774A1 (en) 2018-05-03
KR20180016418A (ko) 2018-02-14
RU2721551C2 (ru) 2020-05-20
JP2018515543A (ja) 2018-06-14
BE1023528A1 (fr) 2017-04-21
DK3297977T3 (da) 2020-03-16
NL2014828B1 (en) 2017-01-31
NL2014828A (en) 2016-11-28
IL255721A (en) 2018-01-31
CN107635949A (zh) 2018-01-26
RU2017143907A (ru) 2019-06-20
US10344045B2 (en) 2019-07-09
US20190276487A1 (en) 2019-09-12

Similar Documents

Publication Publication Date Title
BR112017024734A2 (pt) método e dispositivo para realizar uma pluralidade de processos de síntese de preparação de um radiofármaco em série, e, cassete.
SI3577110T1 (sl) 8-oksetan-3-IL-3,8-diazabiciklo(3.2.1)oktan-3-IL substituirane spojine kot zaviralci HIV-a
AR105634A1 (es) Anticuerpos que se unen a il 8 y sus usos
CL2016003263A1 (es) Composiciones enriquecidas esteroquímicamente para la liberación de ácidos nucléicos.
NZ742040A (en) Engineered nucleic-acid targeting nucleic acids
WO2013103533A3 (en) Free radical polymerizable compositions comprising ionic silicones
WO2017201456A8 (en) Preparation of si-h containing iodosilanes via halide exchange reaction
LT3331891T (lt) Iš esmės diastereomeriškai gryno fosforodiamidato oligomero gamybos būdas, tokiu būdu pagamintas fosforodiamidato oligomeras, ir farmacinė kompozicija, apimanti tokį fosforodiamidato oligomerą
EA201491195A1 (ru) Способ получения композиции, содержащей галактоолигосахариды
SI3515918T1 (sl) Postopek za pripravo 2-ekso-(2-metilbenziloksi)-1-metil-4-izopropil-7- oksabiciklo(2.2.1)heptana
SG11202011466WA (en) Method for preparing keto-functionalized aromatic (meth)acrylates
BR112017006552A2 (pt) composições e métodos para inibir a atividade biológica de biomoléculas solúveis
EA201890898A1 (ru) Новые соединения и конъюгаты криптофицина, их получение и их терапевтическое применение
SA518392370B1 (ar) مركبات وتراكيب ثلاثي أميد تشتمل عليها
IL291315A (en) A stable and concentrated radiopharmaceutical preparation
EA201791113A1 (ru) Фармацевтические составы в виде гранул, содержащие диметилфумарат
BR112017025872A2 (pt) proteínas de ligação multiespecíficas
ZA202001526B (en) Process for producing (meth)acrylates from glycerol carbonate
MX2016017124A (es) Proceso para la preparacion de acidos 3-hidroxipicolinicos.
EP3567047A4 (en) CHEMICAL METHOD FOR PRODUCING HAMNESS NOT FROM PIG BLOOD
BR112016027930B8 (pt) Recuperação de prata por meio de troca de íons
TR201910519T4 (tr) (Met)akrilat fonksiyonel grupları içeren organopolisiloksan hazırlama prosesi.
DK3923914T3 (da) Afabicin-formulering, fremgangsmåde til fremstilling deraf
SI3356329T1 (sl) Postopek priprave 1-(4-metansulfonil-2-trifluorometil-benzil)-2-metil- 1H-pirolo (2,3-b)piridin-3-il-ocetne kisline
SG11201706922RA (en) Process for producing (meth)acrylic resin composition

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/05/2016, OBSERVADAS AS CONDICOES LEGAIS.